Roberto Walter Dal Negro (Roberto W Dal Negro)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 16

Top Topics

Cross Sectional

Chronic Obstructive Pulmonary Disease

Top Venues

Children (Basel, Switzerland)

Healthcare (Basel, Switzerland)

Therapeutic advances in respiratory disease

International journal of chronic obstructive pulmonary disease

This page only lists publications with an associated author ORCID identifier.

Publications

Roberto Walter Dal Negro, Paola Turco
The Extra Cost Due to Non-Adherence to Inhaled Treatments in Adolescents with Mild-to-Moderate Persistent Asthma. Children (Basel, Switzerland) 10 (4) (2023)
Roberto Walter Dal Negro
Editorial for "Asthma and Its Impact in Adolescents" Special Issue. Children (Basel, Switzerland) 10 (11) (2023)
Roberto Walter Dal Negro, Paola Turco, Massimiliano Povero
Trend of Bronchial Hyperresponsiveness to Methacholine as a Cost Predictor of Mild-to-Moderate Asthma: A Twelve-Month Survey in Teenagers. Children (Basel, Switzerland) 10 (12) (2023)
Roberto Walter Dal Negro, Paola Turco, Massimiliano Povero
Trend of Bronchial Hyperresponsiveness to Methacholine as a Cost Predictor of Mild-to-Moderate Asthma: A Twelve-Month Survey in Teenagers. Children (Basel, Switzerland) 10 (12) (2023)
Roberto Walter Dal Negro, Paola Turco
The Extra Cost Due to Non-Adherence to Inhaled Treatments in Adolescents with Mild-to-Moderate Persistent Asthma. Children (Basel, Switzerland) 10 (4) (2023)
Roberto Walter Dal Negro, Paola Turco
Effects of Adherence to Once-Daily Treatment on Lung Function, Bronchial Hyperreactivity and Health Outcomes in Adolescents with Mild-to-Moderate Asthmoka: A Twelve-Month Survey. Children (Basel, Switzerland) 9 (12) (2022)
Roberto Walter Dal Negro, Paola Turco
Effects of Adherence to Once-Daily Treatment on Lung Function, Bronchial Hyperreactivity and Health Outcomes in Adolescents with Mild-to-Moderate Asthmoka: A Twelve-Month Survey. Children (Basel, Switzerland) 9 (12) (2022)
Roberto Walter Dal Negro, Paola Turco, Massimiliano Povero
Lung Function Can Predict the Expected Inspiratory Airflow Rate through Dry Powder Inhalers in Asthmatic Adolescents. Children (Basel, Switzerland) 9 (3) (2022)
Roberto Walter Dal Negro, Paola Turco
Effects of Adherence to Once-Daily Treatment on Lung Function, Bronchial Hyperreactivity and Health Outcomes in Adolescents with Mild-to-Moderate Asthmoka: A Twelve-Month Survey. Children (Basel, Switzerland) 9 (12) (2022)
Peter M A Calverley, Alberto Papi, Clive Peter Page, Rogliani Paola, Roberto Walter Dal Negro, Mario Cazzola, Arrigo Francesco Giuseppe Cicero, Jadwiga A Wedzicha
The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset. International journal of chronic obstructive pulmonary disease 17 (2022)
Alessandro Zanasi, Roberto Walter Dal Negro
Coughing Can Be Modulated by the Hydration Status in Adolescents with Asthma. Children (Basel, Switzerland) 9 (4) (2022)
Massimiliano Povero, Paola Turco, Roberto Walter Dal Negro
The Emotional Response to Pandemic of Middle- and High-School Students of an Italian Northern Province: The ERP Study. Children (Basel, Switzerland) 9 (1) (2022)
Roberto Walter Dal Negro, Massimiliano Povero
A Bayesian Framework to Assess the Usability of Dry Powder Inhalers in a Cohort of Asthma Adolescents in Italy. Children (Basel, Switzerland) 9 (1) (2021)
Roberto Walter Dal Negro, Paola Turco, Massimiliano Povero
Patients' usability of seven most used dry-powder inhalers in COPD. Multidisciplinary respiratory medicine 14 (2019)
Roberto Walter Dal Negro
COPD: The Annual Cost-Of-Illness during the Last Two Decades in Italy, and Its Mortality Predictivity Power. Healthcare (Basel, Switzerland) 7 (1) (2019)
Roberto Walter Dal Negro, Luca Bonadiman, Paola Turco
Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma. Therapeutic advances in respiratory disease 12 (2019)